Heavy charged particle radiobiology: Using enhanced biological effectiveness and improved beam focusing to advance cancer therapy

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 711, Issue 1-2, 2011, Pages 150-157

  Allen, Christopher ^a   Borak, Thomas B ^a   Tsujii, Hirohiko ^b   Nickoloff, Jac A ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Cancer therapy; DNA damage; Gene expression; Ionizing radiation; Mutagenesis

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ADENOID CYSTIC CARCINOMA; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL CYCLE ARREST; CELL KILLING; CHORDOMA; CHROMOSOME ABERRATION; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; ELECTRON THERAPY; ENHANCED BIOLOGICAL EFFECTIVENESS; GENE EXPRESSION; HADRON; HUMAN; ION THERAPY; LINEAR ENERGY TRANSFER; LUNG NON SMALL CELL CANCER; NONHUMAN; OXYGEN ENHANCEMENT RATIO; PARTICLE RADIATION; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE DISTRIBUTION; RADIATION EXPOSURE; RADIATION MUTAGENESIS; RADIOBIOLOGY; RADIOLOGICAL PARAMETERS; RETROPERITONEAL SARCOMA; REVIEW; SURVIVAL RATE; SURVIVAL TIME;

DNA DAMAGE; GENE EXPRESSION; HEAVY IONS; HUMANS; NEOPLASMS; PROTONS; RADIOBIOLOGY; RELATIVE BIOLOGICAL EFFECTIVENESS;

EID: 79956197259     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2011.02.012     Document Type: Review

References (74)

1. Muller H.J. Artificial transmutation of the gene. Science 1927, 66:84-87.
2. Rutherford E. Atomic projectiles and their collisions with light atoms. Science 1919, 50:467-473.
3. Weber U., Kraft G. Comparison of carbon ions versus protons. Cancer J. 2009, 15:325-332.
4. Bragg W.H. On the ionization of various gases by the alpha particles of radium no. 2. Proc. Phys. Soc. London 1907, 20:523-550.
5. DeLaney T., Kooy H.M. Proton and Charged Particle Radiotherapy 2007, Lippincott, Williams and Wilkins, Philadelphia.
6. Lomax A.J. Charged particle therapy: the physics of interaction. Cancer J. 2009, 15:285-291.
7. Suit H., DeLaney T., Goldberg S., Paganetti H., Clasie B., Gerweck L., Niemierko A., Hall E., Flanz J., Hallman J., Trofimov A. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. Radiother. Oncol. 2010, 95:3-22.
8. Sutherland B.M., Bennett P.V., Schenk H., Sidorkina O., Laval J., Trunk J., Monteleone D., Sutherland J. Clustered DNA damages induced by high and low LET radiation, including heavy ions. Phys. Med. 2001, 17(Suppl. 1):202-204.
9. Hada M., Georgakilas A.G. Formation of clustered DNA damage after high-LET irradiation: a review. J. Radiat. Res. (Tokyo) 2008, 49:203-210.
10. Akiko U., Koichi A., Sachiko K., Yoshiya F., Yoshitaka M., Nobuhiko T., Ryoichi H., Masahiko W., Michael S., Thilo E., Peter P. Comparison of biological effectiveness of carbon-ion beams in Japan and Germany. Int. J. Radiat. Oncol. Biol. Phys. 2009, 73:1545-1551.
11. Fokas E., Kraft G., An H., Engenhart-Cabillic R. Ion beam radiobiology and cancer: time to update ourselves. Biochim. Biophys. Acta 2009, 1796:216-229.
12. Schulz-Ertner D., Jakel O., Schlegel W. Radiation therapy with charged particles. Semin. Radiat. Oncol. 2006, 16:249-259.
13. Paganetti H. Significance and implementation of RBE variations in proton beam therapy. Technol. Cancer Res. Treat. 2003, 2:413-426.
14. Weyrather W.K., Kraft G. RBE of carbon ions: experimental data and the strategy of RBE calculation for treatment planning. Radiother. Oncol. 2004, 73(Suppl. 2):S161-S169.
15. Hodgkins P.S., O'Neil P., Stevens D., Fairman M.P. The severity of alpha-particle-induced DNA damage is revealed by exposure to cell-free extracts. Radiat. Res. 1996, 146:660-667.
16. Okayasu R., Okada M., Okabe A., Noguchi M., Takakura K., Takahashi S. Repair of DNA damage induced by accelerated heavy ions in mammalian cells proficient and deficient in the non-homologous end-joining pathway. Radiat. Res. 2006, 165:59-67.
17. Tsao D., Kalogerinis P., Tabrizi I., Dingfelder M., Stewart R.D., Georgakilas A.G. Induction and processing of oxidative clustered DNA lesions in 56Fe-ion-irradiated human monocytes. Radiat. Res. 2007, 168:87-97.
18. Georgakilas A.G., Bennett P.V., Wilson D.M., Sutherland B.M. Processing of bistranded abasic DNA clusters in gamma-irradiated human hematopoietic cells. Nucleic Acids Res. 2004, 32:5609-5620.
19. Weyrather W.K., Debus J. Particle beams for cancer therapy. Clin. Oncol. 2003, 15:S23-S28.
20. Parodi K., Enghardt W., Haberer T. In-beam PET measurements of beta+ radioactivity induced by proton beams. Phys. Med. Biol. 2002, 47:21-36.
21. Kluge T., Mockel D., Pawelke J., Enghardt W. First in-beam PET measurement of beta+ radioactivity induced by hard photon beams. Phys. Med. Biol. 2007, 52:N467-N473.
22. Ponisch F., Parodi K., Hasch B.G., Enghardt W. The modelling of positron emitter production and PET imaging during carbon ion therapy. Phys. Med. Biol. 2004, 49:5217-5232.
23. Iliakis G., Wu W., Wang M. DNA double strand break repair inhibition as a cause of heat radiosensitization: re-evaluation considering backup pathways of NHEJ. Int. J. Hyperthermia 2008, 24:17-29.
24. Harrison L.B., Chadha M., Hill R.J., Hu K., Shasha D. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist 2002, 7:492-508.
25. Vallerga A.K., Zarling D.A., Kinsella T.J. New radiosensitizing regimens, drugs, prodrugs, and candidates. Clin. Adv. Hematol. Oncol. 2004, 2:793-805.
26. Barker C.A., Powell S.N. Enhancing radiotherapy through a greater understanding of homologous recombination. Semin. Radiat. Oncol. 2010, 20:267-273.
27. Vens C., Begg A.C. Targeting base excision repair as a sensitization strategy in radiotherapy. Semin. Radiat. Oncol. 2010, 20:241-249.
28. Luo Y., Leverson J.D. New opportunities in chemosensitization and radiosensitization: modulating the DNA-damage response. Expert Rev. Anticancer Ther. 2005, 5:333-342.
29. Greenberger J.S. Radioprotection. In Vivo 2009, 23:323-336.
30. Delanian S., Lefaix J.L. Current management for late normal tissue injury: radiation-induced fibrosis and necrosis. Semin. Radiat. Oncol. 2007, 17:99-107.
31. Li F., Huang Q., Chen J., Peng Y., Roop D.R., Bedford J.S., Li C.Y. Apoptotic cells activate the "phoenix rising" pathway to promote wound healing and tissue regeneration. Sci. Signal. 2010, 3:ra13.
32. Asaithamby A., Uematsu N., Chatterjee A., Story M.D., Burma S., Chen D.J. Repair of HZE-particle-induced DNA double-strand breaks in normal human fibroblasts. Radiat. Res. 2008, 169:437-446.
33. Sekine E., Okada M., Matsufuji N., Yu D., Furusawa Y., Okayasu R. High LET heavy ion radiation induces lower numbers of initial chromosome breaks with minimal repair than low LET radiation in normal human cells. Mutat. Res. 2008, 652:95-101.
34. Deng Z., Bald I., Illenberger E., Huels M.A. Reactive scattering damage to DNA components by hyperthermal secondary ions. Phys. Rev. Lett. 2006, 96:243203.
35. Masumura K.-i., Kuniya K., Kurobe T., Fukuoka M., Yatagai F., Nohmi T. Heavy-ion-induced mutations in the gpt delta transgenic mouse: comparison of mutation spectra induced by heavy-ion, X-ray, and γ-ray radiation. Environ. Mol. Mutagen. 2002, 40:207-215.
36. Dang H.M., van Goethem M.J., van der Graaf E.R., Brandenburg S., Hoekstra R., Schlathölter T. Plasmid DNA damage by heavy ions at spread-out Bragg peak energies. Eur. Phys. J. 2010, D 60:51-58.
37. Kronenberg A. Mutation induction in human lymphoid cells by energetic heavy ions. Adv. Space Res. 1994, 14:339-346.
38. Weil M.M., Bedford J.S., Bielefeldt-Ohmann H., Ray F.A., Genik P.C., Ehrhart E.J., Fallgren C.M., Hailu F., Battaglia C.L., Charles B., Callan M.A., Ullrich R.L. Incidence of acute myeloid leukemia and hepatocellular carcinoma in mice irradiated with 1GeV/nucleon (56)Fe ions. Radiat. Res. 2009, 172:213-219.
39. Deckbar D., Birraux J., Krempler A., Tchouandong L., Beucher A., Walker S., Stiff T., Jeggo P., Löbrich M. Chromosome breakage after G2 checkpoint release. J. Cell Biol. 2007, 176:749-755.
40. Lobrich M., Jeggo P.A. The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nat. Rev. Cancer 2007, 7:861-869.
41. Durante M., Cucinotta F.A. Heavy ion carcinogenesis and human space exploration. Nat. Rev. Cancer 2008, 8:465-472.
42. Suzuki M., Kase Y., Yamaguchi H., Kanai T., Ando K. Relative biological effectiveness for cell-killing effect on various human cell lines irradiated with heavy-ion medical accelerator in Chiba (HIMAC) carbon-ion beams. Int. J. Radiat. Oncol. Biol. Phys. 2000, 48:241-250.
43. Durante M., George K., Yang T.C. Biodosimetry of ionizing radiation by selective painting of prematurely condensed chromosomes in human lymphocytes. Radiat. Res. 1997, 148:S45-S50.
44. Edwards A.A. The use of chromosomal aberrations in human lymphocytes for biological dosimetry. Radiat. Res. 1997, 148:S39-S44.
45. Lucas J.N. Dose reconstruction for individuals exposed to ionizing radiation using chromosome painting. Radiat. Res. 1997, 148:S33-S38.
46. Wu H., Durante M., George K., Yang T.C. Induction of chromosome aberrations in human cells by charged particles. Radiat. Res. 1997, 148:S102-S107.
47. Amundson S.A. Functional genomics in radiation biology: a gateway to cellular systems-level studies. Radiat. Environ. Biophys. 2008, 47:25-31.
48. Ando S., Nojima K., Ishihara H., Suzuki M., Ando M., Majima H., Ando K., Kuriyama T. Induction by carbon-ion irradiation of the expression of vascular endothelial growth factor in lung carcinoma cells. Int. J. Radiat. Biol. 2000, 76:1121-1127.
49. Fujimori A., Yaoi T., Ogi H., Wang B., Suetomi K., Sekine E., Yu D., Kato T., Takahashi S., Okayasu R., Itoh K., Fushiki S. Ionizing radiation downregulates ASPM, a gene responsible for microcephaly in humans. Biochem. Biophys. Res. Commun. 2008, 369:953-957.
50. Wilson R.R. Radiological use of fast protons. Radiology 1946, 47:487-491.
51. Jereczek-Fossa B.A., Krengli M., Orecchia R. Particle beam radiotherapy for head and neck tumors: radiobiological basis and clinical experience. Head Neck 2006, 28:750-760.
52. M. Jermann, Hadron Therapy Patient Statistics, Particle Therapy Co-Operative Group (PTCOG), 2010.
53. M. Jermann, Particle Therapy Facilities in Operation (Incl. Patient Statistics), Particle Therapy Co-Operative Group (PTCOG), 2010.
54. Nikoghosyan A.V., Karapanagiotou-Schenkel I., Münter M.W., Jensen A.D., Combs S.E., Debus J. Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-study. BMC Cancer 2010, 10:607.
55. Okada T., Kamada T., Tsuji H., Mizoe J.E., Baba M., Kato S., Yamada S., Sugahara S., Yasuda S., Yamamoto N., Imai R., Hasegawa A., Imada H., Kiyohara H., Jingu K., Shinoto M., Tsujii H. Carbon ion radiotherapy: clinical experiences at National Institute of Radiological Science (NIRS). J. Radiat. Res. (Tokyo) 2010, 51:355-364.
56. PTCOG Particle Therapy Facilities in a Planning Stage or Under Construction, Particle Therapy Co-Operative Group (PTCOG), 2010.
57. Goitein M. Radiation Oncology: A Physicist's-Eye View 2007, Springer Science/Business Media, LLC, New York.
58. Kamada T., Tsujii H., Tsuji H., Yanagi T., Mizoe J.E., Miyamoto T., Kato H., Yamada S., Morita S., Yoshikawa K., Kandatsu S., Tateishi A. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J. Clin. Oncol. 2002, 20:4466-4471.
59. Blakely E.A., Kronenberg A. Heavy-ion radiobiology: new approaches to delineate mechanisms underlying enhanced biological effectiveness. Radiat. Res. 1998, 150:S126-S145.
60. Tsujii H., Kamada T., Baba M., Tsuji H., Kato H., Kato S., Yamada S., Yasuda S., Yanagi T., Kato H., Hara R., Yamamoto N., Mizoe J. Clinical advantages of carbon-ion radiotherapy. New J. Phys. 2008, 10:1-16.
61. Durante M., Loeffler J.S. Charged particles in radiation oncology. Nat. Rev. Clin. Oncol. 2010, 7:37-43.
62. Brower V. Carbon ion therapy to debut in Europe. J. Natl. Cancer Inst. 2009, 101:74-76.
63. Iseli T.A., Karnell L.H., Graham S.M., Funk G.F., Buatti J.M., Gupta A.K., Robinson R.A., Hoffman H.T. Role of radiotherapy in adenoid cystic carcinoma of the head and neck. J. Laryngol. Otol. 2009, 123:1137-1144.
64. Mendenhall W.M., Morris C.G., Amdur R.J., Werning J.W., Hinerman R.W., Villaret D.B. Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck 2004, 26:154-162.
65. Pommier P., Liebsch N.J., Deschler D.G., Lin D.T., McIntyre J.F., Barker F.G., Adams J.A., Lopes V.V., Varvares M., Loeffler J.S., Chan A.W. Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch. Otolaryngol. Head Neck Surg. 2006, 132:1242-1249.
66. Catton C., O'Sullivan B., Bell R., Laperriere N., Cummings B., Fornasier V., Wunder J. Chordoma: long-term follow-up after radical photon irradiation. Radiother. Oncol. 1996, 41:67-72.
67. Munzenrider J.E., Liebsch N.J. Proton therapy for tumors of the skull base. Strahlenther. Onkol. 1999, 175(Suppl. 2):57-63.
68. Schulz-Ertner D., Karger C.P., Feuerhake A., Nikoghosyan A., Combs S.E., Jakel O., Edler L., Scholz M., Debus J. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int. J. Radiat. Oncol. Biol. Phys. 2007, 68:449-457.
69. Krempien R., Roeder F., Oertel S., Weitz J., Hensley F.W., Timke C., Funk A., Lindel K., Harms W., Buchler M.W., Debus J., Treiber M. Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma. Int. J. Radiat. Oncol. Biol. Phys. 2006, 65:773-779.
70. Serizawa I., Kagei K., Kamada T., Imai R., Sugahara S., Okada T., Tsuji H., Ito H., Tsujii H. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas. Int. J. Radiat. Oncol. Biol. Phys. 2009, 75:1105-1110.
71. Shioyama Y., Tokuuye K., Okumura T., Kagei K., Sugahara S., Ohara K., Akine Y., Ishikawa S., Satoh H., Sekizawa K. Clinical evaluation of proton radiotherapy for non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2003, 56:7-13.
72. Miyamoto T., Yamamoto N., Nishimura H., Koto M., Tsujii H., Mizoe J.E., Kamada T., Kato H., Yamada S., Morita S., Yoshikawa K., Kandatsu S., Fujisawa T. Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother. Oncol. 2003, 66:127-140.
73. Miyamoto T., Baba M., Yamamoto N., Koto M., Sugawara T., Yashiro T., Kadono K., Ezawa H., Tsujii H., Mizoe J.E., Yoshikawa K., Kandatsu S., Fujisawa T. Curative treatment of stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. Int. J. Radiat. Oncol. Biol. Phys. 2007, 67:750-758.
74. Miyamoto T., Baba M., Sugane T., Nakajima M., Yashiro T., Kagei K., Hirasawa N., Sugawara T., Yamamoto N., Koto M., Ezawa H., Kadono K., Tsujii H., Mizoe J.E., Yoshikawa K., Kandatsu S., Fujisawa T. Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J. Thorac. Oncol. 2007, 2:916-926.